Trial intelligence / Profile preview

Pharmacokinetics of ertapenem in severe sepsis with intraabdominal infection

2009-015948-42Phase 4Completed

Sponsor
University of Tartu
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ertapenem in sepsis, Intra-abdominal infection (IAI), peritonitis and 1 more, sponsored by University of Tartu. Primary endpoint: concentration of ertapenem in abdominal cavity. Started Oct 2009; status: completed.

02

Drugs

ertapenem
03

Conditions

sepsisIntra-abdominal infection (IAI)peritonitispancreatitis

Beyond the preview

Go deeper on 2009-015948-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015948-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call